Biogen | BIIB - هزینه PE به سود





Pe تغییر دادن تاریخ
AbbVie 24.03 86.23 2025-12
Acadia Pharmaceuticals 11.61 2.09 2025-12
ALKERMES 19.54 4.64 2025-12
Amgen 25.31 15.82 2025-12
Bayer 5.93 0.68 2025-09
Biogen 14.02 4.63 2025-12
BioMarin Pharmaceutical 19.24 0.21 2025-12
Bristol-Myers Squibb 9.28 1.04 2025-12
Eli Lilly 40.21 9.66 2025-12
Esperion Therapeutics 129.79 129 2024-12
Gilead Sciences 15.63 0.08 2025-12
Incyte 14.84 2.79 2025-12
Merck 13.92 5.08 2025-12
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 835.47 802.2 2025-12
Novartis 17.85 2.11 2025-12
Pfizer 14.48 5.18 2025-12
PTC Therapeutics 9.98 3.25 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Regeneron Pharmaceuticals 18.11 2.91 2025-12
Sanofi 11.99 1.58 2025-12
Sanofi 15.75 1.53 2025-12
Sarepta Therapeutics 27.27 0 2025-09
Teva Pharmaceutical Industries 10.11 1.04 2025-12
United Therapeutics 17.32 1.62 2025-12
Vertex Pharmaceuticals 26.15 2.22 2025-12